These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 25584808)

  • 21. Correction of glucocerebrosidase deficiency after retroviral-mediated gene transfer into hematopoietic progenitor cells from patients with Gaucher disease.
    Fink JK; Correll PH; Perry LK; Brady RO; Karlsson S
    Proc Natl Acad Sci U S A; 1990 Mar; 87(6):2334-8. PubMed ID: 2315324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. High throughput screening for small molecule therapy for Gaucher disease using patient tissue as the source of mutant glucocerebrosidase.
    Goldin E; Zheng W; Motabar O; Southall N; Choi JH; Marugan J; Austin CP; Sidransky E
    PLoS One; 2012; 7(1):e29861. PubMed ID: 22272254
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polyhydroxylated bicyclic isoureas and guanidines are potent glucocerebrosidase inhibitors and nanomolar enzyme activity enhancers in Gaucher cells.
    Trapero A; Alfonso I; Butters TD; Llebaria A
    J Am Chem Soc; 2011 Apr; 133(14):5474-84. PubMed ID: 21413704
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Activity of glucocerebrosidase in extracts of different cell types from type 1 Gaucher disease patients.
    Sa Miranda MC; Aerts JM; Pinto R; Fontes A; de Lacerda LW; van Weely S; Barranger J; Tager JM
    Clin Genet; 1990 Sep; 38(3):218-27. PubMed ID: 2225530
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gaucher disease: the effects of phosphatidylserine on glucocerebrosidase from normal and Gaucher fibroblasts.
    Choy FY
    Hum Genet; 1984; 67(4):432-6. PubMed ID: 6436168
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identification and characterization of ambroxol as an enzyme enhancement agent for Gaucher disease.
    Maegawa GH; Tropak MB; Buttner JD; Rigat BA; Fuller M; Pandit D; Tang L; Kornhaber GJ; Hamuro Y; Clarke JT; Mahuran DJ
    J Biol Chem; 2009 Aug; 284(35):23502-16. PubMed ID: 19578116
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterization of glucocerebrosidase in Greek Gaucher disease patients: mutation analysis and biochemical studies.
    Michelakakis H; Dimitriou E; Van Weely S; Boot RG; Mavridou I; Verhoek M; Aerts JM
    J Inherit Metab Dis; 1995; 18(5):609-15. PubMed ID: 8598642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gaucher disease: comparative study of acid phosphatase and glucocerebrosidase in normal and type-1 Gaucher tissues.
    Choy FY
    Am J Med Genet; 1985 Jul; 21(3):519-28. PubMed ID: 4025386
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Decreased glucocerebrosidase activity in Gaucher disease parallels quantitative enzyme loss due to abnormal interaction with TCP1 and c-Cbl.
    Lu J; Chiang J; Iyer RR; Thompson E; Kaneski CR; Xu DS; Yang C; Chen M; Hodes RJ; Lonser RR; Brady RO; Zhuang Z
    Proc Natl Acad Sci U S A; 2010 Dec; 107(50):21665-70. PubMed ID: 21098288
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gaucher disease: functional expression of the normal glucocerebrosidase and Gaucher T1366G and G1604A alleles in Baculovirus-transfected Spodoptera frugiperda cells.
    Choy FY; Wei C; Levin D
    Am J Med Genet; 1996 Oct; 65(3):184-9. PubMed ID: 9240741
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A glucocerebrosidase fusion gene in Gaucher disease. Implications for the molecular anatomy, pathogenesis, and diagnosis of this disorder.
    Zimran A; Sorge J; Gross E; Kubitz M; West C; Beutler E
    J Clin Invest; 1990 Jan; 85(1):219-22. PubMed ID: 2295698
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prenatal lethality of a homozygous null mutation in the human glucocerebrosidase gene.
    Tayebi N; Cushner SR; Kleijer W; Lau EK; Damschroder-Williams PJ; Stubblefield BK; Den Hollander J; Sidransky E
    Am J Med Genet; 1997 Nov; 73(1):41-7. PubMed ID: 9375921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A critical histidine residue within LIMP-2 mediates pH sensitive binding to its ligand β-glucocerebrosidase.
    Zachos C; Blanz J; Saftig P; Schwake M
    Traffic; 2012 Aug; 13(8):1113-23. PubMed ID: 22537104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A nonsense mutation in the LIMP-2 gene associated with progressive myoclonic epilepsy and nephrotic syndrome.
    Balreira A; Gaspar P; Caiola D; Chaves J; Beirão I; Lima JL; Azevedo JE; Miranda MC
    Hum Mol Genet; 2008 Jul; 17(14):2238-43. PubMed ID: 18424452
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification of pharmacological chaperones for Gaucher disease and characterization of their effects on beta-glucocerebrosidase by hydrogen/deuterium exchange mass spectrometry.
    Tropak MB; Kornhaber GJ; Rigat BA; Maegawa GH; Buttner JD; Blanchard JE; Murphy C; Tuske SJ; Coales SJ; Hamuro Y; Brown ED; Mahuran DJ
    Chembiochem; 2008 Nov; 9(16):2650-62. PubMed ID: 18972510
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interaction between parkin and mutant glucocerebrosidase variants: a possible link between Parkinson disease and Gaucher disease.
    Ron I; Rapaport D; Horowitz M
    Hum Mol Genet; 2010 Oct; 19(19):3771-81. PubMed ID: 20643691
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gaucher disease-associated glucocerebrosidases show mutation-dependent chemical chaperoning profiles.
    Sawkar AR; Adamski-Werner SL; Cheng WC; Wong CH; Beutler E; Zimmer KP; Kelly JW
    Chem Biol; 2005 Nov; 12(11):1235-44. PubMed ID: 16298303
    [TBL] [Abstract][Full Text] [Related]  

  • 38. New insights into the pharmacological chaperone activity of c2-substituted glucoimidazoles for the treatment of Gaucher disease.
    Li Z; Li T; Dai S; Xie X; Ma X; Zhao W; Zhang W; Li J; Wang PG
    Chembiochem; 2013 Jul; 14(10):1239-47. PubMed ID: 23775891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A new glucocerebrosidase-deficient neuronal cell model provides a tool to probe pathophysiology and therapeutics for Gaucher disease.
    Westbroek W; Nguyen M; Siebert M; Lindstrom T; Burnett RA; Aflaki E; Jung O; Tamargo R; Rodriguez-Gil JL; Acosta W; Hendrix A; Behre B; Tayebi N; Fujiwara H; Sidhu R; Renvoise B; Ginns EI; Dutra A; Pak E; Cramer C; Ory DS; Pavan WJ; Sidransky E
    Dis Model Mech; 2016 Jul; 9(7):769-78. PubMed ID: 27482815
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mutations causing Gaucher disease.
    Horowitz M; Zimran A
    Hum Mutat; 1994; 3(1):1-11. PubMed ID: 8118460
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.